Skip to main content
. 2016 Nov 4;7(50):83148–83159. doi: 10.18632/oncotarget.13074

Figure 2. Pro-inflammatory cytokines enriched in ovarian cancer patient derived ascites.

Figure 2

A. Human cytokine array. The array key represents the location of each antibody in duplicate on the membrane. Peritoneal fluid collected from patients with benign condition (top two panels) and ovarian cancer patient derived ascites (bottom two panels). B. Relative intensity of each spot on the membranes were measured and normalized to the reference spot (RS). Representative cytokines enriched in ovarian cancer patient derived ascites are listed on the graph. C. Human cytokine array panel. D. IL-6 concentration in ovarian cancer patient derived ascites. The concentration of IL-6 was determined by ELISA.